Psilocybin for Palliative Care: Psilocybin Therapy for Demoralized Adults Near the End of Life

This multicenter, triple-blind, phase 2, randomized controlled trial will evaluate the efficacy and safety of psilocybin therapy compared to an active control in treating demoralization in adults near the end of life (≤2 years life expectancy).

We are not actively recruiting for this trial, to learn about other open trials click the button below: